Statizoid

Myanmar vs Zimbabwe: Average cost of drugs for extensively drug-resistant tuberculosis

Myanmar
963 constant 2022 US$
in 2024
Zimbabwe
852 constant 2022 US$
in 2023
Myanmar rank
43rd
Zimbabwe rank
45th

Average cost of drugs for extensively drug-resistant tuberculosis over time

  • Myanmar
  • Zimbabwe
02.5k5.0k7.5k10.0k12.5k201720202024

How they compare

Myanmar currently reports 963 constant 2022 US$ against 852 constant 2022 US$ in Zimbabwe, a difference of 111 constant 2022 US$.

That makes Myanmar's figure about 1.1 times Zimbabwe's.

The two have swapped places 3 times across 6 shared years of data; in 2017 it was Zimbabwe ahead.

Myanmar ranks 43rd and Zimbabwe ranks 45th of 56 countries.

Individual pages

About this data

Indicator
Average cost of drugs for extensively drug-resistant tuberculosis
Unit
constant 2022 US$
Source
WHO (2025) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
56 places, 394 data points, 2017–2024
Last refreshed

Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.